Results 11 to 20 of about 16,221 (209)

Hyperpyrexia After Rectal Misoprostol Administration-A Rare Side Effect of Misoprostol: Case Report

open access: yesNovelty in Biomedicine, 2022
Background: Misoprostol is a safe drug that is one of the prostaglandins analogs. It has uterotonic solid potential and is good for postpartum hemorrhage (PPH).
Masoumeh Mirzamoradi, Yekta Parsa
doaj   +2 more sources

Misoprostol versus Letrozol with Misoprostol in Management of First Trimesteric Missed Miscarriage [PDF]

open access: yesAl-Azhar International Medical Journal, 2021
Background and objective: The objective of this work is to match the security and effectiveness of two treatment modalities (Misoprostol versus Letrozol with Misoprostol) in medical treatment of 1st trimesteric missed miscarriages.
Mofeed Mohammed   +2 more
doaj   +1 more source

Evaluation of Low-dose and High-dose Intravaginal Misoprostol for Induction of Labour: A Randomised, Double-blinded, Single Centre Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2022
Introduction: Misoprostol is a synthetic prostaglandin E1 analogue widely used for cervical ripening and labour induction. However, optimal dose of misoprostol required to induce labour is still controversial.
Gowthami Mummalaneni   +4 more
doaj   +1 more source

Potency and acceptability of oral misoprostol compared with vaginal misoprostol prior to first trimester abortion [PDF]

open access: yesNew Indian Journal of OBGYN, 2020
Objectives: Present study was done to assess the effectiveness and acceptability of oral misoprostol compared with vaginal misoprostol for cervical priming before termination of first trimester pregnancy.
Varsha Kotwal
doaj   +1 more source

The difference of Bishop score change and labor event between oral and vaginal misoprostol in pregnancy beyond 41 weeks

open access: yesMajalah Obstetri dan Ginekologi, 2023
HIGHLIGHTS • Oral misoprostol is more effective than vaginal misoprostol in cervical ripening as a part of induction of labor. • Oral misoprostol is as safe as vaginal misoprostol.   ABSTRACT Objective: To compare Bishop score changes and labor
Maskasoni Maskasoni   +1 more
doaj   +1 more source

Abortion-A brief description of the evolution of methods. [PDF]

open access: yesActa Obstet Gynecol Scand
Termination of pregnancy is not a “modern” societal issue, but one that has been afforded to women, albeit with varying degrees of success, over many centuries. Methods have evolved which have increased the availability, effectiveness, and safety of abortion, while substantially reducing associated morbidity.
Slade L, Deussen A, Dodd J.
europepmc   +2 more sources

Comparative Study of Oral and Vaginal Misoprostol for Induction of Labour, Maternal and Foetal Outcome [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2013
Background: Misoprostol is a new promising agent for cervical ripening and induction of labour .The ideal dose, route and frequency of administration of misoprostol are still under investigation.
Kambhampati Komala   +4 more
doaj   +1 more source

Should oral misoprostol be used to prevent postpartum haemorrhage in home-birth settings in low-resource countries? A systematic review of the evidence. [PDF]

open access: yes, 2012
BACKGROUND: Using misoprostol to prevent postpartum haemorrhage (PPH) in home-birth settings remains controversial. OBJECTIVES: To review the safety and effectiveness of oral misoprostol in preventing PPH in home-birth settings.
Avan, B.I.   +14 more
core   +1 more source

Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review

open access: yesBMC Women's Health, 2020
Background A wide range of drugs have been studied for first trimester medical abortion. Studies evaluating different regimens, including combination mifepristone and misoprostol and misoprostol alone regimens, show varying results related to safety ...
Ferid A. Abubeker   +3 more
doaj   +1 more source

Gastric Output of Pancreatic Secretory Trypsin-Inhibitor Is Increased by Misoprostol [PDF]

open access: yes, 1991
Pancreatic secretory trypsin inhibitor (PSTI) is a potent protease inhibitor that also has growth promoting activity. It has recently been identified in the foveolar cells of the stomach, which secrete mucus.
Batten, J J   +14 more
core   +1 more source

Home - About - Disclaimer - Privacy